Antinociceptive activity of furan-containing congeners of improgan and ranitidine
- 1 October 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (20) , 5715-5719
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cannabinoid–improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptorEuropean Journal of Pharmacology, 2006
- Antinociceptive activity of chemical congeners of improgan: Optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesicNeuropharmacology, 2006
- Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor AgonistThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Activation of brain stem nuclei by improgan, a non-opioid analgesicBrain Research, 2004
- Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological EffectsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Cloning, Expression, and Pharmacological Characterization of a Novel Human Histamine ReceptorMolecular Pharmacology, 2001
- Antinociceptive Activity of Derivatives of Improgran and BurimamidePharmacology Biochemistry and Behavior, 1999
- Novel Qualitative Structure-Activity Relationships for the Antinociceptive Actions of H2 Antagonists, H3Antagonists and DerivativesThe Journal of Pharmacology and Experimental Therapeutics, 1997
- The Disposition of Thioperamide, a Histamine H3-Receptor Antagonist, in RatsJournal of Pharmacy and Pharmacology, 1994
- Cimetidine penetrates brain and inhibits non-opiate footshock-induced analgesiaPharmacology Biochemistry and Behavior, 1986